Metlife Inc (MET) Shares Bought by Dean Investment Associates LLC
Dean Investment Associates LLC boosted its position in shares of Metlife Inc (NYSE:MET) by 4.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,386 shares of the financial services provider’s stock after acquiring an additional 2,151 shares during the quarter. Dean Investment Associates LLC’s holdings in Metlife were worth $2,273,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Osborn Williams & Donohoe LLC acquired a new stake in Metlife in the 1st quarter valued at about $26,000. Jackson Grant Investment Advisers Inc. raised its position in Metlife by 4,407.7% in the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 586 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 573 shares in the last quarter. JNBA Financial Advisors acquired a new stake in Metlife in the 4th quarter valued at about $26,000. Bruderman Asset Management LLC acquired a new stake in Metlife in the 4th quarter valued at about $27,000. Finally, Semmax Financial Advisors Inc. raised its position in Metlife by 1,223.6% in the 1st quarter. Semmax Financial Advisors Inc. now owns 728 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 673 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.
Shares of NYSE MET opened at $48.13 on Thursday. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.24. Metlife Inc has a fifty-two week low of $37.76 and a fifty-two week high of $50.40. The stock has a market cap of $45.74 billion, a PE ratio of 8.93, a price-to-earnings-growth ratio of 1.01 and a beta of 1.21.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 13th. Stockholders of record on Tuesday, May 7th will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.66%. The ex-dividend date is Monday, May 6th. This is a positive change from Metlife’s previous quarterly dividend of $0.42. Metlife’s dividend payout ratio (DPR) is 32.65%.
MET has been the topic of a number of analyst reports. Wells Fargo & Co reaffirmed a “buy” rating and issued a $55.00 price target on shares of Metlife in a research report on Tuesday. Argus reaffirmed a “buy” rating on shares of Metlife in a research report on Tuesday, February 12th. Sandler O’Neill lowered Metlife from a “buy” rating to a “hold” rating and set a $50.00 price target on the stock. in a research report on Tuesday, March 19th. ValuEngine raised Metlife from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Finally, Deutsche Bank increased their price target on Metlife from $46.00 to $47.00 and gave the company a “hold” rating in a research report on Friday, April 12th. Eight research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $52.17.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: What is the 52-week high/low?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.